((RAIN)) Rainmakers-Island

[nonewname1]

Rain, I have a question if you have time. Hopefully you get a look at an interesting biotech reverse merger stock in the process.

The companies name is Oncolix. Their phase one candidate, prolanta, has orphan status for ovarian cancer, is in pre clinical for other cancers and they have raised 16 million to date.

They bought the shell AEPP (.04 93 mil o/s). However they used specific language that said they weren't sure whether they were going public and still evaluating their options.

Now yesterday on their website they posted a new document that mentions they plan on going public in 2017.

https://nebula.wsimg.com/958d9ddf6832c4839ad62b613bbc5288?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

When they bought the shell the o/s I believe was around 30 mil and they purchased around 60 mil shares from the CEO for 300k giving them 2/3 control of the o/s.

Since then they've filed a lot of filings like this where the officers disclaim any beneficial ownership of the shares, it also lists the 61 mil shares in each of the officers names

http://ih.advfn.com/p.php?pid=nmona&article=74351577

My question of course is about the possibility of a reverse split. I believe I've seen r/m stocks reverse commons to death then just issue the officers preferred shares so they keep majority ownership. Do you think that is a possibility here?

I ask because any gentle reverse split where the 60 mil shares they own keep them in power would still lead to big gains if/when they go public.

Sorry to impose with this long question, if you had time to read what do you think?

Link to the page, information in the ibox,

http://investorshub.advfn.com/Advanced-Environmental-Petroleum-AEPP-31408/